Pharmaceutical Standardization Of Tejashiladi vati and its Clinical efficacy in Madhumeha(Type 2 Diabetes Mellitus) - TJSV

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients having Blood sugar â?? Fasting Plasma Glucose >= 126 mg/dl or
•â?? Post Prandial Plasma Glucose >= 200 mg/dl or
•or HB1AC level >7 and <10
•2.Patients having classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata, Galatalu Shosha, Asyamadhurya etc.) will be selected from OPD and IPD of IPGT & RA, Hospital, Jamnagar.
•3.Patients fulfilling criteria 1 with or without criteria 2
•4.Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight loss.)

•1.Age below 30 and above 60 years.
•2.Malignant and accelerated Hypertension.
•3.Patients having chronic complications of Diabetes Mellitus
•a.Microvascular: Retinopathy, Neuropathy, & Nephropathy.
•b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
•c.Other chronic debilitating diseases like STD etc.
•4.Pregnant women.
•5.Lactating mothers.
•6.Secondary Diabetes mellitus.
•7.Patients of any other severe illness.

发起方

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar